A Randomised, Open-label, Multi-centre Trial Investigating the Intra-subject Variability of ROTEM and TEG Parameters Following Two Intravenous Administrations of the Same Dose of Activated Recombinant Factor VII (rFVIIa/NovoSeven) in Haemophilia Patients in a Non-bleeding State

Trial Profile

A Randomised, Open-label, Multi-centre Trial Investigating the Intra-subject Variability of ROTEM and TEG Parameters Following Two Intravenous Administrations of the Same Dose of Activated Recombinant Factor VII (rFVIIa/NovoSeven) in Haemophilia Patients in a Non-bleeding State

Completed
Phase of Trial: Phase I

Latest Information Update: 16 May 2016

At a glance

  • Drugs Eptacog alfa (Primary)
  • Indications Haemophilia A; Haemophilia B
  • Focus Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top